/
© 2026 RiffOn. All rights reserved.
  1. Drug Diaries
  2. This New Test Might Change Cancer Forever!
This New Test Might Change Cancer Forever!

This New Test Might Change Cancer Forever!

Drug Diaries · Jan 25, 2026

Delphi Diagnostics CEO Susan Tucci discusses a revolutionary blood test using AI to detect cancer early, making life-saving tech accessible to all.

Simple Blood Tests Democratize Cancer Screening by Removing Geographic Barriers

Unlike imaging that requires specialized centers, blood tests can be administered anywhere with basic phlebotomy services. This eliminates geographic and logistical barriers, making advanced diagnostics accessible to rural and underserved populations and reframing access as a human right.

This New Test Might Change Cancer Forever! thumbnail

This New Test Might Change Cancer Forever!

Drug Diaries·a month ago

Biotech Leaders Must Intentionally Choose the Hardest, Most Rewarding Missions

According to Delphi CEO Susan Tucci, biotech leadership is a unique challenge that requires deliberately choosing difficult but highly rewarding paths. This mindset is crucial for motivating teams through long, arduous development cycles, as the mission's profound impact justifies the struggle.

This New Test Might Change Cancer Forever! thumbnail

This New Test Might Change Cancer Forever!

Drug Diaries·a month ago

Frame Engineering as Societal Impact, Not Just Tech, to Attract Diverse Talent

Delphi CEO Susan Tucci was inspired to pursue engineering because her teachers framed it as a way to improve lives and communities. This mission-driven narrative, rather than a purely technical one, was crucial for attracting her into a male-dominated field, offering a lesson for modern talent acquisition.

This New Test Might Change Cancer Forever! thumbnail

This New Test Might Change Cancer Forever!

Drug Diaries·a month ago

Modern Cancer Blood Tests Originated from Accidental Findings in Prenatal Screenings

The technology for detecting cancer via cell-free DNA was discovered by accident. During non-invasive prenatal tests, some abnormal results weren't from the baby but from the mother's previously undiagnosed tumors shedding DNA, revealing an entirely new application for the technology.

This New Test Might Change Cancer Forever! thumbnail

This New Test Might Change Cancer Forever!

Drug Diaries·a month ago

Leaders Must Prioritize Decisiveness to Protect Teams From the Paralysis of Ambiguity

Delphi's CEO Susan Tucci views decisiveness as a critical leadership function. While data is important, she believes teams perform poorly in ambiguous environments. Therefore, a leader's primary responsibility is often to make a clear, timely judgment call to keep the team moving forward.

This New Test Might Change Cancer Forever! thumbnail

This New Test Might Change Cancer Forever!

Drug Diaries·a month ago

Delphi Diagnostics Makes Cancer Tests Affordable by Shifting Complexity from Lab Work to AI

To achieve an affordable price for its advanced cancer test, Delphi prioritizes algorithmic complexity over "wet lab" complexity. This strategy keeps physical sample processing simple and low-cost, putting the innovation into scalable software (AI/ML) to analyze the data, which is key for mass adoption.

This New Test Might Change Cancer Forever! thumbnail

This New Test Might Change Cancer Forever!

Drug Diaries·a month ago

Lung Cancer Kills More People Annually Than Breast, Cervical, and Colorectal Cancers Combined

The episode highlights the shocking scale of lung cancer's impact, stating it causes more deaths each year than several other major cancers combined. This stark comparison underscores the critical need for better and more accessible screening technologies, as current methods like CT scans are highly underutilized.

This New Test Might Change Cancer Forever! thumbnail

This New Test Might Change Cancer Forever!

Drug Diaries·a month ago